The global plant genomics market size reached US$ 10.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.33% during 2024-2032. Plant genomics refer to numerous genetic manipulation methods that are used to improve plant quality and aim to determine the manner genetic composition of plants affects plant breeding. With numerous advancements in plant genomics, crop protection may be improved by preventing mycotoxin contamination in plants and allowing crops to survive extreme temperatures. The availability of faster growing plants contributes to maintaining food security and ensuring that nutrients are available in the market. Plant genomics also plays an instrumental role in reducing the spread of diseases through the development of genetically modified crops. Molecular diagnostics, molecular markers, genetic engineering, tissue culture, and the development of beneficial microbes are the main areas of genomics that are employed to improve the quality of crops. Plant Genomics Market Trends: The market is majorly driven by the rising prevalence of protein deficiency among individuals, resulting in the augmenting demand for protein-rich plants. The market is experiencing an increase in the demand for fruit, vegetables, and cereals of high quality due to the increasing population. Also, extensive research and development (R&D) activities conducted for developing numerous advanced plant genomics methods are creating a positive outlook for the market. Apart from this, favorable initiatives taken by the government bodies of several countries promoting improved plant and crop growth programs are providing an impetus to the market. Additionally, the widespread loss of vegetative cover is resulting in the implementation of alternative scientific methods to improve vegetation and increase plant productivity. The market is further propelled by the shifting preference toward genomics over automated instruments due to its cost-efficiency and the growing costs of automated instruments. Some of the other factors contributing to the market include the escalating demand for a bio-based economy to improve food security, rapid urbanization, considerable growth in the food and beverage (F&B) industry, the rising trend of veganism and an enhanced focus on sustainable development. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global plant genomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, trait and application. Breakup by Type: Molecular Engineering Genetic Engineering Genome Editing Others Breakup by Technology: DNA/RNA Sequencing Genotyping Marker-Assisted Selection (MAS) Bioinformatics Others Breakup by Trait: Yield Improvement Disease Resistance Herbicide Tolerance Others Breakup by Application: Cereals and Grains Oilseeds and Pulses Fruits and Vegetables Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., BGI Genomics, Eurofins Scientific SE, Floragenex Inc., GENEWIZ Inc. (Azenta Inc.), Illumina Inc., Keygene N.V., LC Sciences, Neogen Corporation, Novogene Co. Ltd., NRGene Technologies Ltd., Oxford Nanopore Technologies plc and Qiagen N.V. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report. Key Questions Answered in This Report: How has the global plant genomics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global plant genomics market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the technology? What is the breakup of the market based on the trait? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global plant genomics market and who are the key players? What is the degree of competition in the industry?

1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Plant Genomics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 Molecular Engineering 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Genetic Engineering 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Genome Editing 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Technology 7.1 DNA/RNA Sequencing 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Genotyping 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Marker-Assisted Selection (MAS) 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Bioinformatics 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Trait 8.1 Yield Improvement 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Disease Resistance 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Herbicide Tolerance 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Application 9.1 Cereals and Grains 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Oilseeds and Pulses 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Fruits and Vegetables 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia-Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Agilent Technologies Inc 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 BGI Genomics 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 Financials 15.3.3 Eurofins Scientific SE 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.3.3 Financials 15.3.3.4 SWOT Analysis 15.3.4 Floragenex Inc 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.5 GENEWIZ Inc. (Azenta Inc.) 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.6 Illumina Inc 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 Financials 15.3.6.4 SWOT Analysis 15.3.7 Keygene N.V 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.8 LC Sciences 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.9 Neogen Corporation 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.9.4 SWOT Analysis 15.3.10 Novogene Co. Ltd 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.11 NRGene Technologies Ltd 15.3.11.1 Company Overview 15.3.11.2 Product Portfolio 15.3.11.3 Financials 15.3.12 Oxford Nanopore Technologies plc 15.3.12.1 Company Overview 15.3.12.2 Product Portfolio 15.3.12.3 Financials 15.3.12.4 SWOT Analysis 15.3.13 Qiagen N.V 15.3.13.1 Company Overview 15.3.13.2 Product Portfolio 15.3.13.3 Financials 15.3.13.4 SWOT Analysis